Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Gabapentin 300mg capsules
0408010G0AAABAB
|
Gabapentin | Gabapentin | Central Nervous System | 261,728 |
|
Gabapentin 100mg capsules
0408010G0AAAAAA
|
Gabapentin | Gabapentin | Central Nervous System | 180,786 |
|
Gabapentin 600mg tablets
0408010G0AAAJAJ
|
Gabapentin | Gabapentin | Central Nervous System | 96,928 |
|
Gabapentin 400mg capsules
0408010G0AAACAC
|
Gabapentin | Gabapentin | Central Nervous System | 67,109 |
|
Gabapentin 50mg/ml oral solution sugar free
0408010G0AABGBG
|
Gabapentin | Gabapentin | Central Nervous System | 13,647 |
|
Gabapentin 800mg tablets
0408010G0AAAKAK
|
Gabapentin | Gabapentin | Central Nervous System | 9,923 |
|
Gabapentin 400mg/5ml oral suspension
0408010G0AABHBH
|
Gabapentin | Gabapentin | Central Nervous System | 108 |
|
Gabapentin 250mg/5ml oral liquid
0408010G0AAAQAQ
|
Gabapentin | Gabapentin | Central Nervous System | 103 |
|
Gabapentin 100mg/5ml oral suspension
0408010G0AAAGAG
|
Gabapentin | Gabapentin | Central Nervous System | 59 |
|
Gabapentin 100mg/5ml oral solution
0408010G0AABIBI
|
Gabapentin | Gabapentin | Central Nervous System | 50 |
|
Gabapentin 300mg/5ml oral liquid
0408010G0AAAPAP
|
Gabapentin | Gabapentin | Central Nervous System | 40 |
|
Gabapentin 400mg/5ml oral solution
0408010G0AAAYAY
|
Gabapentin | Gabapentin | Central Nervous System | 11 |
|
Gabapentin 500mg/5ml oral liquid
0408010G0AAAVAV
|
Gabapentin | Gabapentin | Central Nervous System | 10 |
|
Gabapentin 200mg/5ml oral liquid
0408010G0AAAWAW
|
Gabapentin | Gabapentin | Central Nervous System | 6 |
|
Gabapentin 50mg/5ml oral liquid
0408010G0AAASAS
|
Gabapentin | Gabapentin | Central Nervous System | 6 |
|
Gabapentin 150mg/5ml oral liquid
0408010G0AAANAN
|
Gabapentin | Gabapentin | Central Nervous System | No data available |
|
Gabapentin 450mg/5ml oral liquid
0408010G0AAARAR
|
Gabapentin | Gabapentin | Central Nervous System | No data available |
|
Gabapentin 600mg tablets and Gabapentin 300mg capsules
0408010G0AAAXAX
|
Gabapentin | Gabapentin | Central Nervous System | No data available |
|
Gabapentin 600mg/5ml oral liquid
0408010G0AABBBB
|
Gabapentin | Gabapentin | Central Nervous System | No data available |
|
Gabapentin 800mg/5ml oral liquid
0408010G0AABCBC
|
Gabapentin | Gabapentin | Central Nervous System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.